Simona Mencej-Bedrač1, Janez Preželj, Janja Marc. 1. University of Ljubljana, Faculty of Pharmacy, Department of Clinical Biochemistry, Askerceva cesta 7, SI-1000 Ljubljana, Slovenia. simona.mencej@ffa.uni-lj.si
Abstract
OBJECTIVES: Osteoprotegerin (OPG) inhibits osteoclast function by acting as a decoy receptor for receptor activator of nuclear factor-κB ligand (RANKL), thus being an important candidate gene for osteoporosis. Three recent genome-wide association studies also identified the TNFRSF11B gene, coding for OPG, as playing a key role in bone mineral density (BMD) regulation. As variations in the TNFRSF11B gene could alter the susceptibility to osteoporosis, the aim of study was to investigate association of two TNFRSF11B gene polymorphisms with BMD and serum OPG concentration in postmenopausal women. STUDY DESIGN: 478 postmenopausal women were genotyped for the presence of TNFRSF11B gene polymorphisms 245T > G (rs3134069) and 1181G > C (rs2073618). BMDs and serum OPG concentrations were measured. RESULTS: Two common haplotypes GT and CT occurred in 41.2% and 52.4% of subjects. In osteoporotic postmenopausal women, lumbar spine BMD was associated with polymorphisms 245T > G and 1181G > C, as well as with CT haplotype (p values 0.013, 0.006 and 0.006, respectively). Additionally, femoral neck BMD showed the association with 245T > G (p = 0.047). No other statistically significant associations with BMD were found for the studied SNPs and haplotypes. No association with serum OPG concentration was shown in any of the studied groups. CONCLUSIONS: Our results suggest that, in postmenopausal osteoporosis, polymorphisms 245T > G and 1181G > C, as well as haplotype CT in TNFRSF11B gene influence BMD.
OBJECTIVES:Osteoprotegerin (OPG) inhibits osteoclast function by acting as a decoy receptor for receptor activator of nuclear factor-κB ligand (RANKL), thus being an important candidate gene for osteoporosis. Three recent genome-wide association studies also identified the TNFRSF11B gene, coding for OPG, as playing a key role in bone mineral density (BMD) regulation. As variations in the TNFRSF11B gene could alter the susceptibility to osteoporosis, the aim of study was to investigate association of two TNFRSF11B gene polymorphisms with BMD and serum OPG concentration in postmenopausal women. STUDY DESIGN: 478 postmenopausal women were genotyped for the presence of TNFRSF11B gene polymorphisms 245T > G (rs3134069) and 1181G > C (rs2073618). BMDs and serum OPG concentrations were measured. RESULTS: Two common haplotypes GT and CT occurred in 41.2% and 52.4% of subjects. In osteoporotic postmenopausal women, lumbar spine BMD was associated with polymorphisms 245T > G and 1181G > C, as well as with CT haplotype (p values 0.013, 0.006 and 0.006, respectively). Additionally, femoral neck BMD showed the association with 245T > G (p = 0.047). No other statistically significant associations with BMD were found for the studied SNPs and haplotypes. No association with serum OPG concentration was shown in any of the studied groups. CONCLUSIONS: Our results suggest that, in postmenopausal osteoporosis, polymorphisms 245T > G and 1181G > C, as well as haplotype CT in TNFRSF11B gene influence BMD.
Authors: Saba Abdi; Rawan A Binbaz; Abdul Khader Mohammed; Mohammed G A Ansari; Kaiser Wani; Osama E Amer; Abdullah M Alnaami; Naji Aljohani; Nasser M Al-Daghri Journal: Genes (Basel) Date: 2021-01-29 Impact factor: 4.096
Authors: R M R Pereira; C P Figueiredo; C C Cha; V F Caparbo; R M Oliveira; A S Franco; P R Menezes; I de Castro; L F Onuchic Journal: Osteoporos Int Date: 2016-06-16 Impact factor: 4.507
Authors: Iwona Krela-Kaźmierczak; Marta Kaczmarek-Ryś; Aleksandra Szymczak; Michał Michalak; Marzena Skrzypczak-Zielińska; Natalia Drwęska-Matelska; Michalina Marcinkowska; Piotr Eder; Lilianna Łykowska-Szuber; Ewa Wysocka; Krzysztof Linke; Ryszard Słomski Journal: Calcif Tissue Int Date: 2016-09-17 Impact factor: 4.333
Authors: Jasmin Teresa Ney; Ingolf Juhasz-Boess; Frank Gruenhage; Stefan Graeber; Rainer Maria Bohle; Michael Pfreundschuh; Erich Franz Solomayer; Gunter Assmann Journal: BMC Cancer Date: 2013-01-31 Impact factor: 4.430
Authors: Jung Oh Kim; Soo Hong Han; Yeon Ho Lee; Tae Keun Ahn; Jae Joon Lim; Young Sun Chung; Dong Eun Shin; Woo Sik Lee; In Bo Han; Nam Keun Kim Journal: Int J Mol Sci Date: 2016-12-09 Impact factor: 5.923